MSACL 2014 EU September 1 Austria 2-5, 2014 Salzburg, Con Dence in Results MSACL 2014 EU
Total Page:16
File Type:pdf, Size:1020Kb
The Association for MS Mass Spectrometry: ACL Applications to the Clinical Lab MSACL 2014 EU September 2-5, 2014 Salzburg, Austria 1 2014 EU September MSACL Condence in Results MSACL 2014 EU ™ high-performance medical devices for in vitro diagnostic use ™ Prelude MD ™ ™ Endura MD ™ mass spectrometer, and Thermo Salzburg, Austria ™ ClinQuan MD ™ LC-MS for in vitro diagnostic use September 2-5 The 1st Annual European Congress Visit us in booth #12 • st Annual European Congress Program Congress Annual European e licensed for limited use only to Thermo r d parties including Shutterstock, and a r by thi Supported in part by generous contributions from: For in vitro diagnostic use. Not available in all countries. San Jose, CA USA i s Endura MD Mass ISO 13485 Prelude MD HPLC Spectrometer ClinQuan MD Software AD64157-EN 0614S-Rev.B MSACLMASS SPECTROMETRY SOLUTIONS FOR IN2014 VITRO DIAGNOSTICS EU The variety of your clinical research Salzburg, Austria demands a variety of technologies September 2-5 The 1st Annual European Congress You’re not the only one who needs to trust the test results ACCURACY THE FIRST TIME No one analytical technology can adequately reveal everything you need ! GC-Triple Quadrupole to know about your sample. Bruker offers the broadest range of high ! LC-Triple Quadrupole Clinicians and patients count on the most reliable diagnostic answers. We want you to be confident that results are as timely performance, easy-to-use, and expertly supported analytical systems ! LC-QqTOF and accurate as possible. SCIEX Diagnostics offers an in vitro diagnostics solution with exceptional assay performance that helps to overcome any clinical research challenge. Our proven, extremely overcome the limitations of current testing methods. Our newly introduced assays for Vitamin D, Newborn Screening and robust GC-Triple Quads, LC-Triple Quads, Ion Traps and QqTOFs ensure Immunosuppressants accurately measure multiple analytes in a single run, and virtually eliminate the need for re-runs and confidence in your results for microbiology, biomarker discovery, tissue send-outs. And not only are SCIEX Diagnostics solutions backed by over 25 years of leadership in mass spectrometry, imaging, and drugs of abuse or drug monitoring research. they are surprisingly affordable, too. Get the right answer faster, more cost effectively, using the appropriate Find out how SCIEX Diagnostics can help improve your accuracy, turnaround and confidence analytical technology for the job – Bruker’s complementary solutions for at www.sciexdiagnostics.com. clinical research. Come and visit us at MSACL, Booth 10 and 11. Visit us at MSACL, Booth 15 and on the Web at www.bruker.com Diagnostics GC/LC/MS Systems For In Vitro Diagnostic Use. Not available in all countries. © 2014 AB SCIEX. SCIEX is part of AB SCIEX. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license. Innovation with Integrity IVD-MKT-13-1360-A For research use only. Not for use in diagnostic procedures. MSACL 2014 EU The First Annual European Congress of The Association for Mass Spectrometry: Applications to the Clinical Lab Salzburg, AUSTRIA September 2 - 5, 2014 Salzburg Congress Center The Association is a non-membership, non-profit 501(c)(3) tax-exempt California Corporation with the mission of furthering education in the field of mass spectrometry. Go Mobile! Mobile Program @ https://www.msacl.org/mobile Get Connected with BadgeScanTM. The Official Contact & Lead Capture App of MSACL 2014 EU. 1 MSACL 2015 US San Diego March 28 - April 1 The 7th Annual US Conference on Clinical Mass Spectrometry Travel Award & Podium Submission Deadline: December 4, 2014 Presented by: The Association for MS Mass Spectrometry: ACL Applications to the Clinical Lab Supported by: Table of Contents CORPORATE SPONSORS .................................................................................................................... 4 SCIENTIFIC COMMITTEE ................................................................................................................. 5 GENERAL INFORMATION ............................................................................................................... 17 PRESENTER INFO AND GUIDELINES ........................................................................................... 18 SCHEDULE OVERVIEW .................................................................................................................... 19 TUESDAY ......................................................................................................................... 19 WEDNESDAY ................................................................................................................... 19 THURSDAY ...................................................................................................................... 20 FRIDAY ............................................................................................................................ 21 PLENARY SPEAKER SERIES ........................................................................................................... 23 YOUNG INVESTIGATOR AWARDS ................................................................................................ 25 TRAINEE AWARDS ............................................................................................................................ 26 SHORT COURSE OVERVIEW .......................................................................................................... 27 EXHIBITS SUMMARY ........................................................................................................................ 30 EXHIBITORS ........................................................................................................................................ 31 CORPORATE WORKSHOPS ............................................................................................................. 35 PODIUM PRESENTATIONS .............................................................................................................. 39 POSTER PRESENTATIONS ............................................................................................................... 53 POSTERS BY TOPIC ......................................................................................................... 54 POSTERS: WEDNESDAY .............................................................................................. 67 POSTERS: THURSDAY ................................................................................................. 77 POSTERS: FRIDAY ........................................................................................................ 91 PRESENTER INDEX ........................................................................................................................... 99 MAP: 2ND FLOOR ............................................................................................................................... 100 MAP: 1ST FLOOR - EXHIBIT HALL ................................................................................................ 101 MAP: GROUND FLOOR ................................................................................................................... 102 3 Corporate Sponsors 4 Scientific Committee Please take a moment to acknowledge the members of the Scientific Committee of this inaugural congress who were pivitoal in the development of the Scientific Program. Theodore Alexandrov, PhD University of Bremen, Germany / SCiLS, Germany / UCSD, USA Jean Armengaud, PhD CEA-Marcoule, France Olof Beck, PhD Karolinska Institutet, Sweden Karl-Siegfried Boos, PhD Professor of Clinical Chemistry Institute of Laboratory Medicine, Medical Center of the University, Munich, Germany Uta Ceglarek, PhD, EurClinChem Leipzig University Olivier Gaillot, PhD Centre de Biologie Pathologie, CHU de Lille, France Roland Geyer Tecan Switzerland AG Brian Keevil, PhD Department of Clinical Biochemistry, University Hospital of South Manchester, Manchester, UK Pierre Marquet, MD, PhD University of Limoges, France 5 Oleg Mayboroda, PhD Leiden University Medical Center, The Netherlands Prof. Dr. med. Soren Schubert Ludwig-Maximilians-Universitat (LMU) Munchen Christoph Seger, PhD University Hospital Innsbruck Zoltan Takats, PhD Imperial College, London, UK Prof. Dr. med. Michael Vogeser Institute of Laboratory Medicine, Hospital of the University of Munich, Germany for the working group LC-MS/MS of the DGKL Stefan Zimmermann, MD University Hospital Heidelberg, Germany 6 Geotrichum Fusobacterium Lodderomyces Anaerococcus Colletotrichum Edwardsiella Comamonas Pigmentiphaga Moellerella Nesterenkonia Listonella Udeniomyces Erysipelothrix Escherichia Streptomyces Bartonella Hafnia Terrimonas Pseudoxanthomonas Corynebacterium Streptococcus Aerococcus Saccharothrix Facklamia Schizosaccharomyces Tetragenococcus Lechevalieria Clavibacter Shimwellia Brachybacterium Leclercia Providencia Trabulsiella Xanthobacter Emericella Gardnerella Sporothrix Leuconostoc Pseudoclavibacter Alkalibacillus Debaryomyces Turicella Roseomonas Ruminococcus Scedosporium Dysgonomonas Staphylococcus Peptostreptococcus Paenibacillus Balneatrix Solibacillus Prototheca Cupriavidus Geobacillus Aspergillus Arthrobacter Mesorhizobium Acholeplasma Filobasidium Propioniferax Azohydromonas Chromobacterium Curtobacterium Kloeckera Austwickia Hyphomicrobium Cryptococcus Rummeliibacillus Budvicia Aquincola Enterobacter Sporobolomyces Brevundimonas Capnocytophaga